NDC 50242-583 – Xofluza
Baloxavir Marboxil 40 mg/20mL · Granule, For Solution · Oral
Product NDC50242-583
Product details
- Brand name
- Xofluza
- Generic name
- Baloxavir Marboxil
- Labeler
- Genentech, Inc.
- Dosage form
- Granule, For Solution
- Route
- Oral
- Marketing category
- NDA · NDA214410
- Marketed since
- October 24, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- Polymerase Acidic Endonuclease Inhibitor
Active ingredients
- Baloxavir Marboxil 40 mg/20mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50242-583-01 | 1 BOTTLE, GLASS in 1 CARTON (50242-583-01) / 20 mL in 1 BOTTLE, GLASS | Nov 23, 2020 |
Other Xofluza products
- 50242-599 Baloxavir Marboxil 30 mg/1 · Granule, For Suspension · Genentech, Inc.
- 50242-617 Baloxavir Marboxil 40 mg/1 · Granule, For Suspension · Genentech, Inc.
- 50242-860 Baloxavir Marboxil 40 mg/1 · Tablet, Film Coated · Genentech, Inc.
- 50242-877 Baloxavir Marboxil 80 mg/1 · Tablet, Film Coated · Genentech, Inc.
- 85766-058 Baloxavir Marboxil 80 mg/1 · Tablet, Film Coated · Sportpharm LLC